Sergei Tjulandin - Researcher Profile

Publications

2 shown

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff , Thomas J. Ervin , Francis P. Arena +20 more

In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but...

2013 New England Journal of Medicine 6383 citations

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem , Vladimir Moiseyenko , Sergei Tjulandin +9 more

Purpose In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorourac...

2006 Journal of Clinical Oncology 1912 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 8,295
Institution: Fundación Arturo López Pérez

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9807-2229

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.